Global Buprenorphine Patches Market Research Report 2024

Publication ID:

PB509243505

Publication Date:

September 20, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Buprenorphine patches are a form of transdermal medication used primarily for pain management and, in some cases, for the treatment of opioid dependence. Buprenorphine is a partial opioid agonist, which means it activates opioid receptors in the brain but to a lesser extent than full agonists like morphine or heroin. This property makes it effective for pain relief while also reducing the risk of misuse and dependence.
The global Buprenorphine Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Buprenorphine Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Buprenorphine Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Buprenorphine Patches include Mundipharma, Gr眉nenthal GmbH, Purdue Pharma, Teva Pharmaceuticals, Sandoz (a division of Novartis), Camurus AB, Endo Pharmaceuticals, Pfizer, Mylan (now part of Viatris), Indivior, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Buprenorphine Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Buprenorphine Patches.
The Buprenorphine Patches market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Buprenorphine Patches market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Buprenorphine Patches manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Mundipharma
Gr眉nenthal GmbH
Purdue Pharma
Teva Pharmaceuticals
Sandoz (a division of Novartis)
Camurus AB
Endo Pharmaceuticals
Pfizer
Mylan (now part of Viatris)
Indivior
Hisamitsu Pharmaceutical Co., Inc.
Alvogen
Segment by Type
<10 Micrograms
鈮�10 Micrograms
Segment by Application
Hospital
Clinic
Pharmacy
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Buprenorphine Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Buprenorphine Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Buprenorphine Patches Market Overview
1.1 Product Definition
1.2 Buprenorphine Patches by Type
1.2.1 Global Buprenorphine Patches Market Value Comparison by Type (2024-2030)
1.2.2 <10 Micrograms
1.2.3 鈮�10 Micrograms
1.3 Buprenorphine Patches by Application
1.3.1 Global Buprenorphine Patches Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Other
1.4 Global Buprenorphine Patches Market Size Estimates and Forecasts
1.4.1 Global Buprenorphine Patches Revenue 2019-2030
1.4.2 Global Buprenorphine Patches Sales 2019-2030
1.4.3 Global Buprenorphine Patches Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Buprenorphine Patches Market Competition by Manufacturers
2.1 Global Buprenorphine Patches Sales Market Share by Manufacturers (2019-2024)
2.2 Global Buprenorphine Patches Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Buprenorphine Patches Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Buprenorphine Patches, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Buprenorphine Patches, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Buprenorphine Patches, Product Type & Application
2.7 Global Key Manufacturers of Buprenorphine Patches, Date of Enter into This Industry
2.8 Global Buprenorphine Patches Market Competitive Situation and Trends
2.8.1 Global Buprenorphine Patches Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Buprenorphine Patches Players Market Share by Revenue
2.8.3 Global Buprenorphine Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Buprenorphine Patches Market Scenario by Region
3.1 Global Buprenorphine Patches Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Buprenorphine Patches Sales by Region: 2019-2030
3.2.1 Global Buprenorphine Patches Sales by Region: 2019-2024
3.2.2 Global Buprenorphine Patches Sales by Region: 2025-2030
3.3 Global Buprenorphine Patches Revenue by Region: 2019-2030
3.3.1 Global Buprenorphine Patches Revenue by Region: 2019-2024
3.3.2 Global Buprenorphine Patches Revenue by Region: 2025-2030
3.4 North America Buprenorphine Patches Market Facts & Figures by Country
3.4.1 North America Buprenorphine Patches Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Buprenorphine Patches Sales by Country (2019-2030)
3.4.3 North America Buprenorphine Patches Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Buprenorphine Patches Market Facts & Figures by Country
3.5.1 Europe Buprenorphine Patches Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Buprenorphine Patches Sales by Country (2019-2030)
3.5.3 Europe Buprenorphine Patches Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Buprenorphine Patches Market Facts & Figures by Region
3.6.1 Asia Pacific Buprenorphine Patches Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Buprenorphine Patches Sales by Region (2019-2030)
3.6.3 Asia Pacific Buprenorphine Patches Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Buprenorphine Patches Market Facts & Figures by Country
3.7.1 Latin America Buprenorphine Patches Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Buprenorphine Patches Sales by Country (2019-2030)
3.7.3 Latin America Buprenorphine Patches Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Buprenorphine Patches Market Facts & Figures by Country
3.8.1 Middle East and Africa Buprenorphine Patches Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Buprenorphine Patches Sales by Country (2019-2030)
3.8.3 Middle East and Africa Buprenorphine Patches Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Buprenorphine Patches Sales by Type (2019-2030)
4.1.1 Global Buprenorphine Patches Sales by Type (2019-2024)
4.1.2 Global Buprenorphine Patches Sales by Type (2025-2030)
4.1.3 Global Buprenorphine Patches Sales Market Share by Type (2019-2030)
4.2 Global Buprenorphine Patches Revenue by Type (2019-2030)
4.2.1 Global Buprenorphine Patches Revenue by Type (2019-2024)
4.2.2 Global Buprenorphine Patches Revenue by Type (2025-2030)
4.2.3 Global Buprenorphine Patches Revenue Market Share by Type (2019-2030)
4.3 Global Buprenorphine Patches Price by Type (2019-2030)
5 Segment by Application
5.1 Global Buprenorphine Patches Sales by Application (2019-2030)
5.1.1 Global Buprenorphine Patches Sales by Application (2019-2024)
5.1.2 Global Buprenorphine Patches Sales by Application (2025-2030)
5.1.3 Global Buprenorphine Patches Sales Market Share by Application (2019-2030)
5.2 Global Buprenorphine Patches Revenue by Application (2019-2030)
5.2.1 Global Buprenorphine Patches Revenue by Application (2019-2024)
5.2.2 Global Buprenorphine Patches Revenue by Application (2025-2030)
5.2.3 Global Buprenorphine Patches Revenue Market Share by Application (2019-2030)
5.3 Global Buprenorphine Patches Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mundipharma
6.1.1 Mundipharma Company Information
6.1.2 Mundipharma Description and Business Overview
6.1.3 Mundipharma Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mundipharma Buprenorphine Patches Product Portfolio
6.1.5 Mundipharma Recent Developments/Updates
6.2 Gr眉nenthal GmbH
6.2.1 Gr眉nenthal GmbH Company Information
6.2.2 Gr眉nenthal GmbH Description and Business Overview
6.2.3 Gr眉nenthal GmbH Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Gr眉nenthal GmbH Buprenorphine Patches Product Portfolio
6.2.5 Gr眉nenthal GmbH Recent Developments/Updates
6.3 Purdue Pharma
6.3.1 Purdue Pharma Company Information
6.3.2 Purdue Pharma Description and Business Overview
6.3.3 Purdue Pharma Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Purdue Pharma Buprenorphine Patches Product Portfolio
6.3.5 Purdue Pharma Recent Developments/Updates
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Company Information
6.4.2 Teva Pharmaceuticals Description and Business Overview
6.4.3 Teva Pharmaceuticals Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Pharmaceuticals Buprenorphine Patches Product Portfolio
6.4.5 Teva Pharmaceuticals Recent Developments/Updates
6.5 Sandoz (a division of Novartis)
6.5.1 Sandoz (a division of Novartis) Company Information
6.5.2 Sandoz (a division of Novartis) Description and Business Overview
6.5.3 Sandoz (a division of Novartis) Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sandoz (a division of Novartis) Buprenorphine Patches Product Portfolio
6.5.5 Sandoz (a division of Novartis) Recent Developments/Updates
6.6 Camurus AB
6.6.1 Camurus AB Company Information
6.6.2 Camurus AB Description and Business Overview
6.6.3 Camurus AB Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Camurus AB Buprenorphine Patches Product Portfolio
6.6.5 Camurus AB Recent Developments/Updates
6.7 Endo Pharmaceuticals
6.7.1 Endo Pharmaceuticals Company Information
6.7.2 Endo Pharmaceuticals Description and Business Overview
6.7.3 Endo Pharmaceuticals Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Endo Pharmaceuticals Buprenorphine Patches Product Portfolio
6.7.5 Endo Pharmaceuticals Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Buprenorphine Patches Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Mylan (now part of Viatris)
6.9.1 Mylan (now part of Viatris) Company Information
6.9.2 Mylan (now part of Viatris) Description and Business Overview
6.9.3 Mylan (now part of Viatris) Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan (now part of Viatris) Buprenorphine Patches Product Portfolio
6.9.5 Mylan (now part of Viatris) Recent Developments/Updates
6.10 Indivior
6.10.1 Indivior Company Information
6.10.2 Indivior Description and Business Overview
6.10.3 Indivior Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Indivior Buprenorphine Patches Product Portfolio
6.10.5 Indivior Recent Developments/Updates
6.11 Hisamitsu Pharmaceutical Co., Inc.
6.11.1 Hisamitsu Pharmaceutical Co., Inc. Company Information
6.11.2 Hisamitsu Pharmaceutical Co., Inc. Description and Business Overview
6.11.3 Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hisamitsu Pharmaceutical Co., Inc. Buprenorphine Patches Product Portfolio
6.11.5 Hisamitsu Pharmaceutical Co., Inc. Recent Developments/Updates
6.12 Alvogen
6.12.1 Alvogen Company Information
6.12.2 Alvogen Description and Business Overview
6.12.3 Alvogen Buprenorphine Patches Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Alvogen Buprenorphine Patches Product Portfolio
6.12.5 Alvogen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Buprenorphine Patches Industry Chain Analysis
7.2 Buprenorphine Patches Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Buprenorphine Patches Production Mode & Process
7.4 Buprenorphine Patches Sales and Marketing
7.4.1 Buprenorphine Patches Sales Channels
7.4.2 Buprenorphine Patches Distributors
7.5 Buprenorphine Patches Customers
8 Buprenorphine Patches Market Dynamics
8.1 Buprenorphine Patches Industry Trends
8.2 Buprenorphine Patches Market Drivers
8.3 Buprenorphine Patches Market Challenges
8.4 Buprenorphine Patches Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Mundipharma
Gr眉nenthal GmbH
Purdue Pharma
Teva Pharmaceuticals
Sandoz (a division of Novartis)
Camurus AB
Endo Pharmaceuticals
Pfizer
Mylan (now part of Viatris)
Indivior
Hisamitsu Pharmaceutical Co., Inc.
Alvogen

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂